UK Companies House feature
ENERGIST LIMITED
Cash
£767K
-23.6% vs 2023
Net assets
£1M
+15.2% vs 2023
Employees
29
+16% vs 2023
Profit before tax
£197K
-71.8% vs 2023
Profile
- Company number
- 04838458
- Status
- Active
- Incorporation
- 2003-07-19
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 32500
- Hubs
- UK Healthcare
Net assets
7-year trend · vs UK Healthcare median
Accounts
7-year trend · latest 2024-12-31
| Metric | Trend | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | — | — | |
| Operating profit | — | — | — | — | — | — | — | |
| Profit before tax | — | — | — | — | — | £696,259 | £196,654 | |
| Net profit | — | — | £625,039 | £143,306 | £440,430 | £702,880 | £196,654 | |
| Cash | — | — | £131,219 | £161,314 | £765,564 | £1,004,203 | £767,218 | |
| Total assets less current liabilities | — | — | £716,957 | £816,170 | £1,314,002 | £1,999,691 | £1,870,379 | |
| Net assets | — | — | £4,420 | £147,726 | £588,156 | £1,291,036 | £1,487,690 | |
| Equity | -£1,146,197 | -£620,619 | £4,420 | £147,726 | £588,156 | £1,291,036 | £1,487,690 | |
| Average employees | — | — | 22 | 21 | 22 | 25 | 29 | |
| Wages | — | — | — | — | — | £1,159,030 | £1,436,788 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- Azets Audit Services
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“Should the forecast level of sales and profitability not be achieved, the business might need to seek further funding in order to bridge the cashflow position. Should this funding not be available, this represents a material uncertainty which may cast significant doubt about the company's ability to continue as a going concern.”
Significant events
- “During the year the Company continued to focus on the development of the enhancement of its NeoGen product range, specifically refining the nitrogen plasma technology.”
- “The Company also appointed several new distributors to increase its geographic coverage.”
- “During 2024 the company continued its collaboration with a Dermatological Testing Company, which led to the publishing of a clinical study report, which identified both visible and statistically significant results, including skin density increasing by an average of 80% and cheek wrinkle reduction by 54% following a course of three low to medium energy treatments.”
- “During the year, NeoGen received numerous awards globally, including Skinceuticals Best Energy Device (highly Recommended), The Aesthetic Awards Best Overall Patient Enhancement and Best Non-Surgical Facial Rejuvenation Enhancement, Greece Medical Beauty Most Innovative Device, Safety In Beauty Best Aesthetic Technology Finalist. In February 2025, NeoGen was awarded Best Treatment for Menopause in Aesthetics.”
- “Operationally the company continued to make improvements to the quality of the devices and manufacturing processes.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
2 active · 27 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| DAVIES, Giles Alexander | Director | 2025-10-13 | Dec 1967 | British |
| JONES, Simon Francis | Director | 2015-04-01 | Jan 1973 | British |
Show 27 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CLEMENT, Mark Rowland | Secretary | 2003-08-13 | 2003-09-26 |
| DAVIES, Geoffrey Clive | Secretary | 2003-09-26 | 2007-05-31 |
| GATEHOUSE, Peter John | Secretary | 2009-09-30 | 2013-11-07 |
| GATEHOUSE, Peter John | Secretary | 2009-09-30 | 2009-09-30 |
| PRUTTON, Jonathan Miles | Secretary | 2007-06-01 | 2009-09-30 |
| MD SECRETARIES LIMITED | Corporate Nominee Secretary | 2003-07-19 | 2003-08-13 |
| BRIARIS, Dennis Alan, Dr | Director | 2003-08-15 | 2007-05-23 |
| CLEMENT, Mark Rowland | Director | 2008-06-01 | 2013-11-11 |
| CLEMENT, Mark Rowland | Director | 2003-08-13 | 2007-03-28 |
| DAVIES, Geoffrey Clive | Director | 2003-12-16 | 2007-05-31 |
| DAVIES, Sarah Louise | Director | 2022-08-08 | 2025-05-28 |
| EVANS, Christopher Thomas, Professor | Director | 2003-08-13 | 2009-07-31 |
| GATEHOUSE, Peter John | Director | 2009-09-30 | 2009-09-30 |
| GATEHOUSE, Peter John | Director | 2009-09-30 | 2013-11-07 |
| GEORGE, David Simon | Director | 2003-08-15 | 2007-12-17 |
| HOPKIN, Ian David, Dr | Director | 2004-12-01 | 2006-10-06 |
| HUMBER, Maxwell John | Director | 2015-08-17 | 2019-04-30 |
| PETERSEN, Ronald John | Director | 2003-09-01 | 2003-12-22 |
| PHILLIPS, Mark | Director | 2014-08-27 | 2015-06-02 |
| PRUTTON, Jonathan Miles | Director | 2007-02-10 | 2013-04-17 |
| SMART, Alexander | Director | 2013-11-11 | 2015-11-12 |
| SODEN, Stephen John | Director | 2004-03-01 | 2004-11-23 |
| THOMAS, Darren Paul | Director | 2015-04-01 | 2016-05-26 |
| TROW, Robert Kenneth George, Dr. | Director | 2015-04-01 | 2016-11-01 |
| WAKEFIELD, James Christopher | Director | 2009-07-10 | 2013-03-22 |
| BEAUBRIDGE ENERGIST LLP | Corporate Director | 2013-11-11 | 2015-11-12 |
| MD DIRECTORS LIMITED | Corporate Nominee Director | 2003-07-19 | 2003-08-13 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Energist Holdings Limited | Corporate entity | Shares 75–100% | 2016-04-06 | Ceased 2016-04-06 |
| Belmont Investments Ltd | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 159 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-10-24 | AP01 | officers | appoint person director company with name date |
| 2025-07-30 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-05-28 | TM01 | officers | termination director company with name termination date |
| 2025-05-27 | AA | accounts | accounts with accounts type full |
| 2024-08-07 | AA | accounts | accounts with accounts type small |
| 2024-07-26 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-03-14 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2024-03-14 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2023-09-12 | MR04 | mortgage | mortgage satisfy charge full |
| 2023-09-12 | MR04 | mortgage | mortgage satisfy charge full |
| 2023-09-12 | MR04 | mortgage | mortgage satisfy charge full |
| 2023-09-06 | AA | accounts | accounts with accounts type small |
| 2023-07-26 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-07-26 | AD01 | address | change registered office address company with date old address new address |
| 2023-07-26 | AD01 | address | change registered office address company with date old address new address |
| 2022-12-14 | MR04 | mortgage | mortgage satisfy charge full |
| 2022-08-08 | AP01 | officers | appoint person director company with name date |
| 2022-07-26 | AA | accounts | accounts with accounts type small |
| 2022-07-19 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-09-30 | AA | accounts | accounts with accounts type small |
Credit score
Altman Z″ (private-firm) · reference 2024-12-31
4.54
SAFE
Altman Z″
- Working capital / Total assets 0.446 × 6.56 = +2.93
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets 0.059 × 6.72 = +0.39
- Book equity / Total liabilities 1.161 × 1.05 = +1.22
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory